GUOFUHEE (02582) plans to repurchase H shares.

19:57 10/12/2025

Guo Fu Hydrogen Energy (02582) announced that it intends to exercise the power granted by the shareholders at the 2024 Annual General Meeting to repurchase the company's shares based on the general authorization. The Board of Directors has decided that, from the date of this announcement until the expiration of the general authorization for repurchase, the company will, based on market conditions and the provisions of the general authorization for repurchase, occasionally repurchase the company's H shares on the Stock Exchange of Hong Kong, with a total repurchase limit of HK$50 million. The source of funds for repurchasing shares is from the company's own funds and does not involve the net proceeds from the company's global offering.

GUOFUHEE (02582) announced that it intends to exercise the power granted by shareholders at the Company's 2024 Annual General Meeting to repurchase shares in accordance with the general mandate. The Board of Directors has decided that, from the date of this announcement until the expiration of the general mandate for repurchase, the Company will, depending on market conditions and the rules of the general mandate for repurchase, from time to time repurchase the Company's H shares on the Stock Exchange of Hong Kong, with a maximum repurchase amount of HK$50 million. The funds for the repurchase of shares will come from the Company's own funds and will not involve the net proceeds from the Company's global offering.

The final sprint of the Hang Seng Stock Connect inspection window: HAIXI PHARMA's "market value safety cushion" and market language.

Soochow: By 2026, the certainty of offshore equipment + AI driving the structural opportunities for improving domestic demand and new technologies.

Montage Technology (688008.SH) successfully obtained approval from the China Securities Regulatory Commission for its overseas listing of shares (H shares).

The final sprint of the Hang Seng Stock Connect inspection window: HAIXI PHARMA's "market value safety cushion" and market language.

Soochow: By 2026, the certainty of offshore equipment + AI driving the structural opportunities for improving domestic demand and new technologies.

Montage Technology (688008.SH) successfully obtained approval from the China Securities Regulatory Commission for its overseas listing of shares (H shares).